Effect of Dietary Linoleic Acid on Markers of Inflammation in Healthy Persons: A Systematic Review of Randomized Controlled Trials

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 7, 2012, Pages

  Johnson, Guy H ^a   Fritsche, Kevin ^b  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

C reactive protein; Inflammation; Linoleic acid; N 6 fatty acids

Indexed keywords

EID: 84862684061     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.03.029     Document Type: Article

References (84)

1. Dietary Guidelines for Americans, 2010 2010, US Government Printing Office, Washington, DC. 7th ed.
2. Harris W.S., Mozaffarian D., Rimm E., et al. Omega-6 fatty acids and risk for cardiovascular disease: A science advisory from the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention. Circulation 2009, 119(6):902-907.
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002, 106(25):3143-3421. National Cholesterol Education Program.
4. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein and Amino Acids 2002, Institute of Medicine, Food and Nutrition Board, National Academies Press, Washington, DC.
5. Dietary Guidelines for Americans, 2005 2005, US Government Printing Office, Washington, DC, Home and Garden Bulletin No. 232. 5th ed.
6. Kris-Etherton P.M., Innis S. Position of the American Dietetic Association and Dietitians of Canada: Dietary fatty acids. J Am Diet Assoc 2007, 107(9):1599-1611. American Dietetic Association, Dietitians of Canada.
7. Innis S.M. Dietary lipids in early development: Relevance to obesity, immune and inflammatory disorders. Curr Opin Endocrinol Diabetes Obes 2007, 14(5):359-364.
8. Lands W.E. Dietary fat and health: The evidence and the politics of prevention: Careful use of dietary fats can improve life and prevent disease. Ann N Y Acad Sci 2005, 1055:179-192.
9. Simopoulos A.P. The omega-6/omega-3 fatty acid ratio, genetic variation, and cardiovascular disease. Asia Pac J Clin Nutr 2008, 17(suppl 1):131-134.
10. Simopoulos A.P. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp Biol Med (Maywood) 2008, 233(6):674-688.
11. Serhan C.N., Yacoubian S., Yang R. Anti-inflammatory and proresolving lipid mediators. Annu Rev Pathol 2008, 3:279-312.
12. Allayee H., Roth N., Hodis H.N. Polyunsaturated fatty acids and cardiovascular disease: Implications for nutrigenetics. J Nutrigenet Nutrigenomics 2009, 2(3):140-148.
13. Das U.N. Essential Fatty acids-A review. Curr Pharm Biotechnol 2006, 7(6):467-482.
14. Fritsche K.L. Too much linoleic acid promotes inflammation-Doesn't it?. Prostaglandins Leukot Essent Fatty Acids 2008, 79(3-5):173-175.
15. Galli C., Calder P.C. Effects of fat and fatty acid intake on inflammatory and immune responses: A critical review. Ann Nutr Metab 2009, 55(1-3):123-139.
16. Harris W.S. Linoleic acid and coronary heart disease. Prostaglandins Leukot Essent Fatty Acids 2008, 79(3-5):169-171.
17. Kapoor R., Huang Y.S. Gamma linolenic acid: An antiinflammatory omega-6 fatty acid. Curr Pharm Biotechnol 2006, 7(6):531-534.
18. Lee J.Y., Zhao L., Hwang D.H. Modulation of pattern recognition receptor-mediated inflammation and risk of chronic diseases by dietary fatty acids. Nutr Rev 2010, 68(1):38-61.
19. Simopoulos A.P. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: Nutritional implications for chronic diseases. Biomed Pharmacother 2006, 60(9):502-507.
20. Simopoulos A.P. Evolutionary aspects of the dietary omega-6:omega-3 fatty acid ratio: medical implications. World Rev Nutr Diet 2009, 100:1-21.
21. Wu D. Modulation of immune and inflammatory responses by dietary lipids. Curr Opin Lipidol 2004, 15(1):43-47.
22. De Lorgeril M. Essential polyunsaturated fatty acids, inflammation, atherosclerosis and cardiovascular diseases. Subcell Biochem 2007, 42:283-297.
23. Calder P.C., Albers R., Antoine J.M., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 101(Suppl 1):S1-S45.
24. Baer D.J., Judd J.T., Clevidence B.A., Tracy R.P. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004, 79(6):969-973.
25. Hoffman D.R., Boettcher J.A., Diersen-Schade D.A. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: A review of randomized controlled trials. Prostaglandins Leukot Essent Fatty Acids 2009, 81(2-3):151-158.
26. Dhingra R., Gona P., Nam B.H., et al. C-reactive protein, inflammatory conditions, and cardiovascular disease risk. Am J Med 2007, 120(12):1054-1062.
27. Federico A., D'Aiuto E., Borriello F., et al. Fat: A matter of disturbance for the immune system. World J Gastroenterol 2010, 16(38):4762-4772.
28. Devaraj S., Kasim-Karakas S., Jialal I. The effect of weight loss and dietary fatty acids on inflammation. Curr Atheroscler Rep 2006, 8(6):477-486.
29. Basu A., Devaraj S., Jialal I. Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol 2006, 26(5):995-1001.
30. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107(3):499-511.
31. Ballantyne C.M., Nambi V. Markers of inflammation and their clinical significance. Atheroscler Suppl 2005, 6(2):21-29.
32. Mensink R.P., Katan M.B. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992, 12(8):911-919.
33. Hegsted D.M., Ausman L.M., Johnson J.A., Dallal G.E. Dietary fat and serum lipids: An evaluation of the experimental data. Am J Clin Nutr 1993, 57(6):875-883.
34. Mensink R.P., Zock P.L., Kester A.D., Katan M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 2003, 77(5):1146-1155.
35. Higgans J., Green S.B. Cochrane handbook for systematic reviews of interventions 2009. Accessed April 1. 2012. http://www.cochrane-handbook.org/.
36. Blair I.A., Prakash C., Phillips M.A., Dougherty R.M., Iacono J.M. Dietary modification of omega 6 fatty acid intake and its effect on urinary eicosanoid excretion. Am J Clin Nutr 1993, (2):154-160.
37. Adam O., Tesche A., Wolfram G. Impact of linoleic acid intake on arachidonic acid formation and eicosanoid biosynthesis in humans. Prostaglandins Leukot Essent Fatty Acids 2008, 79(3-5):177-181.
38. Hwang D.H., Chanmugam P.S., Ryan D.H., et al. Does vegetable oil attenuate the beneficial effects of fish oil in reducing risk factors for cardiovascular disease?. Am J Clin Nutr 1997, (1):89-96.
39. Turpeinen A.M., Pajari A.M., Freese R., Sauer R., Mutanen M. Replacement of dietary saturated by unsaturated fatty acids: Effects of platelet protein kinase C activity, urinary content of 2,3-dinor-TXB2 and in vitro platelet aggregation in healthy man. Thromb Haemost 1998, 80(4):649-655.
40. Oosthuizen W., Vorster H.H., Vermaak W.J., et al. Lecithin has no effect on serum lipoprotein, plasma fibrinogen and macro molecular protein complex levels in hyperlipidaemic men in a double-blind controlled study. Eur J Clin Nutr 1998, 52(6):419-424.
41. Baumann K.H., Hessel F., Larass I., et al. Dietary omega-3, omega-6, and omega-9 unsaturated fatty acids and growth factor and cytokine gene expression in unstimulated and stimulated monocytes. A randomized volunteer study. Arterioscler Thromb Vasc Biol 1999, 19(1):59-66.
42. Turpeinen A.M., Mutanen M. Similar effects of diets high in oleic or linoleic acids on coagulation and fibrinolytic factors in healthy humans. Nutr Metab Cardiovasc Dis 1999, 9(2):65-72.
43. Hunter K.A., Crosbie L.C., Horgan G.W., Miller G.J., Dutta-Roy A.K. Effect of diets rich in oleic acid, stearic acid and linoleic acid on postprandial haemostatic factors in young healthy men. Br J Nutr 2001, 86(2):207-215.
44. Junker R., Kratz M., Neufeld M., et al. Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system. Throm Haemost 2001, (2):280-286.
45. Freese R., Vaarala O., Turpeinen A.M., Mutanen M. No difference in platelet activation or inflammation markers after diets rich or poor in vegetables, berries and apple in healthy subjects. Eur J Nutr 2004, 43(3):175-182.
46. Minihane A.M., Brady L.M., Lovegrove S.S., Lesauvage S.V., Williams C.M., Lovegrove J.A. Lack of effect of dietary n-6:n-3 PUFA ratio on plasma lipids and markers of insulin responses in Indian Asians living in the UK. Eur J Nutr 2005, (1):26-32.
47. Thijssen M.A., Hornstra G., Mensink R.P. Stearic, oleic, and linoleic acids have comparable effects on markers of thrombotic tendency in healthy human subjects. J Nutr 2005, 135(12):2805-2811.
48. Lichtenstein A.H., Matthan N.R., Jalbert S.M., Resteghini N.A., Schaefer E.J., Ausman L.M. Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr 2006, 84(3):497-504.
49. Jones P.J., Demonty I., Chan Y.M., Herzog Y., Pelled D. Fish-oil esters of plant sterols differ from vegetable-oil sterol esters in triglycerides lowering, carotenoid bioavailability and impact on plasminogen activator inhibitor-1 (PAI-1) concentrations in hypercholesterolemic subjects. Lipids Health Dis 2007, 6:28.
50. Liou Y.A., King D.J., Zibrik D., Innis S.M. Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007, 137(4):945-952.
51. Schulz K.F., Chalmers I., Hayes R.J., Altman D.G. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995, 273(5):408-412.
52. Minihane A.M., Brady L.M., Lovegrove S.S., Lesauvage S.V., Williams C.M., Lovegrove J.A. Lack of effect of dietary n-6:n-3 PUFA ratio on plasma lipids and markers of insulin responses in Indian Asians living in the UK. Eur J Nutr 2005, 44(1):26-32.
53. Junker R., Kratz M., Neufeld M., et al. Effects of diets containing olive oil, sunflower oil, or rapeseed oil on the hemostatic system. Thromb Haemost 2001, 85(2):280-286.
54. Peisajovich A., Marnell L., Mold C., Du Clos T.W. C-reactive protein at the interface between innate immunity and inflammation. Expert Rev Clin Immunol 2008, 4(3):379-390.
55. Harris W.S. The omega-6/omega-3 ratio and cardiovascular disease risk: Uses and abuses. Curr Atheroscler Rep 2006, 8(6):453-459.
56. Fats and Fatty Acids in Human Nutrition. Report of an Expert Consultation 2010, Food and Agriculture Organization/World Health Organization, Geneva, Switzerland, FAO Food and Nutrition Paper 91;2010.
57. Harris W.S., Poston W.C., Haddock C.K. Tissue n-3 and n-6 fatty acids and risk for coronary heart disease events. Atherosclerosis 2007, 193(1):1-10.
58. Ferrucci L., Cherubini A., Bandinelli S., et al. Relationship of Plasma Polyunsaturated Fatty Acids to Circulating Inflammatory Markers. J Clin Endocrinol Metab 2006, 91(2):439-446.
59. Pischon T., Hankinson S.E., Hotamisligil G.S., Rifai N., Willett W.C., Rimm E.B. Habitual dietary intake of n-3 and n-6 fatty acids in relation to inflammatory markers among US men and women. Circulation 2003, 108(2):155-160.
60. Yoneyama S., Miura K., Sasaki S., et al. Dietary intake of fatty acids and serum C-reactive protein in Japanese. J Epidemiol 2007, 17(3):86-92.
61. Poudel-Tandukar K., Nanri A., Matsushita Y., et al. Dietary intakes of alpha-linolenic and linoleic acids are inversely associated with serum C-reactive protein levels among Japanese men. Nutr Res 2009, 29(6):363-370.
62. Fernandez-Real J.M., Broch M., Vendrell J., Ricart W. Insulin resistance, inflammation, and serum fatty acid composition. Diabetes Care 2003, 26(5):1362-1368.
63. Klein-Platat C., Drai J., Oujaa M., Schlienger J.L., Simon C. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005, 82(6):1178-1184.
64. Calder P.C. Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale. Biochimie 2009, 91(6):791-795.
65. Deckelbaum R.J., Calder P.C. Dietary n-3 and n-6 fatty acids: Are there 'bad' polyunsaturated fatty acids?. Curr Opin Clin Nutr Metab Care 2010, 13(2):123-124.
66. Nelson G.J., Schmidt P.C., Bartolini G., Kelley D.S., Kyle D. The effect of dietary arachidonic acid on platelet function, platelet fatty acid composition, and blood coagulation in humans. Lipids 1997, 32(4):421-425.
67. Kusumoto A., Ishikura Y., Kawashima H., Kiso Y., Takai S., Miyazaki M. Effects of arachidonate-enriched triacylglycerol supplementation on serum fatty acids and platelet aggregation in healthy male subjects with a fish diet. Br J Nutr 2007, 98(3):626-635.
68. Hirota S., Adachi N., Gomyo T., Kawashima H., Kiso Y., Kawabata T. Low-dose arachidonic acid intake increases erythrocytes and plasma arachidonic acid in young women. Prostaglandins Leukot Essent Fatty Acids 2010, 83(2):83-88.
69. Rett B.S., Whelan J. Increasing dietary linoleic acid does not increase tissue arachidonic acid content in adults consuming Western-type diets: A systematic review. Nutr Metab (Lond) 2011, 8:36.
70. Kelley D.S., Taylor P.C., Nelson G.J., Mackey B.E. Arachidonic acid supplementation enhances synthesis of eicosanoids without suppressing immune functions in young healthy men. Lipids 1998, 33(2):125-130.
71. Thies F., Miles E.A., Nebe-von-Caron G., et al. Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adults. Lipids 2001, 36(11):1183-1193.
72. Miles E.A., Allen E., Calder P.C. In vitro effects of eicosanoids derived from different 20-carbon fatty acids on production of monocyte-derived cytokines in human whole blood cultures. Cytokine 2002, 20(5):215-223.
73. Levy B.D., Clish C.B., Schmidt B., Gronert K., Serhan C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat Immunol 2001, 2(7):612-619.
74. Vachier I., Chanez P., Bonnans C., Godard P., Bousquet J., Chavis C. Endogenous anti-inflammatory mediators from arachidonate in human neutrophils. Biochem Biophys Res Commun 2002, 290(1):219-224.
75. Serhan C.N., Jain A., Marleau S., et al. Reduced inflammation and tissue damage in transgenic rabbits overexpressing 15-lipoxygenase and endogenous anti-inflammatory lipid mediators. J Immunol 2003, 171(12):6856-6865.
76. Serhan C.N. Resolution phase of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007, 25:101-137.
77. Node K., Huo Y., Ruan X., et al. Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids. Science 1999, 285(5431):1276-1279.
78. Oltman C.L., Weintraub N.L., VanRollins M., Dellsperger K.C. Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 1998, 83(9):932-939.
79. Singer P., Jaeger W., Berger I., et al. Effects of dietary oleic, linoleic and alpha-linolenic acids on blood pressure, serum lipids, lipoproteins and the formation of eicosanoid precursors in patients with mild essential hypertension. J Hum Hypertens 1990, 4(3):227-233.
80. Liou Y., Innis S.M. Dietary linoleic acid has no effect on arachidonic acid, but increases n-6 eicosadienoic acid, and lowers dihomo-gamma-linolenic and eicosapentaenoic acid in plasma of adult men. Prostaglandins Leukot Essent Fatty Acids 2009, 80(4):201-206.
81. Goyens P.L., Spilker M.E., Zock P.L., Katan M.B., Mensink R.P. Conversion of alpha-linolenic acid in humans is influenced by the absolute amounts of alpha-linolenic acid and linoleic acid in the diet and not by their ratio. Am J Clin Nutr 2006, 84(1):44-53.
82. Schaeffer L., Gohlke H., Muller M., et al. Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Hum Mol Genet 2006, 15(11):1745-1756.
83. Mathias R.A., Sergeant S., Ruczinski I., et al. The impact of FADS genetic variants on omega 6 polyunsaturated fatty acid metabolism in African Americans. BMC Genet 2011, 12:50.
84. Martinelli N., Girelli D., Malerba G., et al. FADS genotypes and desaturase activity estimated by the ratio of arachidonic acid to linoleic acid are associated with inflammation and coronary artery disease. Am J Clin Nutr 2008, 88(4):941-949.